1203 Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective c-Met inhibition
Year: 2009
Type: conference-abstract
Authors: T.A. Yap, M.P. Lolkema, N. Tunariu, D.S.W. Tan, A.T. Brunetto, M. Germuska, E. Garmey, J. Li, N. de Souza, J.S. de Bono
Language: English
Topic: MRI in cancer diagnosis
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2008625177